"Off-label" use of anti-drowsiness drug skyrockets

By Genevra Pittman NEW YORK (Reuters Health) – The number of Americans taking the narcolepsy and shift work sleep disorder drug modafinil has increased almost 10-fold over the past decade, according to a new study. What’s more, the majority of those prescriptions were written for so-called off-label conditions, such as depression and multiple sclerosis, researchers found. …